Health results? Strong. Market demand? Sky-high. Patient adherence? Dropping.
The demand for GLP-1 medications is unlike anything we’ve seen in modern healthcare. Yet, a significant number of patients abandon the journey during the first year, while others can’t get past the prescription process.
The reality is that clinical efficacy cannot overcome operational friction. Processing delays, insurance hurdles and a lack of support is draining provider resources and getting in the way of patient progress.
To take advantage of this massive opportunity, health platforms need to unite operations and experience to drive growth and retention.
Inside this white paper, we explore:
- The GLP-1 economy: Current market dynamics and the primary challenges facing providers
- The patient journey: Identification of common friction points from initial interest through long-term care
- Operational support: A way to manage acquisition, access and adherence at scale
